Evaluation of a decision-support system for inoperable non-small cell lung cancer

Tuija Wigren, Pentti Kolari

Research output: Contribution to journalArticleScientificpeer-review

5 Citations (Scopus)

Abstract

The purpose of this study was to find out whether a decision-support system is able to assist a clinician in predicting patient outcome and in selecting optimal treatment in oncology. The domain of the evaluated decision-support prototype was primary therapeutic decision making in inoperable non-small cell lung cancer. The performance of the prototype was tested on retrospective material consisting of 112 patients treated by radiotherapy. Survival was the endpoint for examining whether the treatment decision proposed by the system was more accurate than the decision actually made by the clinician. Certain prognostic variables were used by the system to classify patients into two treatment groups, radical or palliative radiotherapy. The median survival times of these groups were 15 and 7 months, respectively, compared with 9 and 8 months in the corresponding groups classified by the clinician. Our results indicate that clinicians need support in treatment selection and that decision-support systems could be a potential answer.
Original languageEnglish
Pages (from-to)397-401
Number of pages5
JournalMethods of Information in Medicine
Volume33
Issue number4
Publication statusPublished - 1994
MoE publication typeA1 Journal article-refereed

Fingerprint

Non-Small Cell Lung Carcinoma
Radiotherapy
Therapeutics
Survival
Decision Making

Cite this

Wigren, Tuija ; Kolari, Pentti. / Evaluation of a decision-support system for inoperable non-small cell lung cancer. In: Methods of Information in Medicine. 1994 ; Vol. 33, No. 4. pp. 397-401.
@article{35b924a68d194302ba62fd2c3e1d869b,
title = "Evaluation of a decision-support system for inoperable non-small cell lung cancer",
abstract = "The purpose of this study was to find out whether a decision-support system is able to assist a clinician in predicting patient outcome and in selecting optimal treatment in oncology. The domain of the evaluated decision-support prototype was primary therapeutic decision making in inoperable non-small cell lung cancer. The performance of the prototype was tested on retrospective material consisting of 112 patients treated by radiotherapy. Survival was the endpoint for examining whether the treatment decision proposed by the system was more accurate than the decision actually made by the clinician. Certain prognostic variables were used by the system to classify patients into two treatment groups, radical or palliative radiotherapy. The median survival times of these groups were 15 and 7 months, respectively, compared with 9 and 8 months in the corresponding groups classified by the clinician. Our results indicate that clinicians need support in treatment selection and that decision-support systems could be a potential answer.",
author = "Tuija Wigren and Pentti Kolari",
year = "1994",
language = "English",
volume = "33",
pages = "397--401",
journal = "Methods of Information in Medicine",
issn = "0026-1270",
publisher = "Thieme Medical Publishers",
number = "4",

}

Evaluation of a decision-support system for inoperable non-small cell lung cancer. / Wigren, Tuija; Kolari, Pentti.

In: Methods of Information in Medicine, Vol. 33, No. 4, 1994, p. 397-401.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Evaluation of a decision-support system for inoperable non-small cell lung cancer

AU - Wigren, Tuija

AU - Kolari, Pentti

PY - 1994

Y1 - 1994

N2 - The purpose of this study was to find out whether a decision-support system is able to assist a clinician in predicting patient outcome and in selecting optimal treatment in oncology. The domain of the evaluated decision-support prototype was primary therapeutic decision making in inoperable non-small cell lung cancer. The performance of the prototype was tested on retrospective material consisting of 112 patients treated by radiotherapy. Survival was the endpoint for examining whether the treatment decision proposed by the system was more accurate than the decision actually made by the clinician. Certain prognostic variables were used by the system to classify patients into two treatment groups, radical or palliative radiotherapy. The median survival times of these groups were 15 and 7 months, respectively, compared with 9 and 8 months in the corresponding groups classified by the clinician. Our results indicate that clinicians need support in treatment selection and that decision-support systems could be a potential answer.

AB - The purpose of this study was to find out whether a decision-support system is able to assist a clinician in predicting patient outcome and in selecting optimal treatment in oncology. The domain of the evaluated decision-support prototype was primary therapeutic decision making in inoperable non-small cell lung cancer. The performance of the prototype was tested on retrospective material consisting of 112 patients treated by radiotherapy. Survival was the endpoint for examining whether the treatment decision proposed by the system was more accurate than the decision actually made by the clinician. Certain prognostic variables were used by the system to classify patients into two treatment groups, radical or palliative radiotherapy. The median survival times of these groups were 15 and 7 months, respectively, compared with 9 and 8 months in the corresponding groups classified by the clinician. Our results indicate that clinicians need support in treatment selection and that decision-support systems could be a potential answer.

M3 - Article

VL - 33

SP - 397

EP - 401

JO - Methods of Information in Medicine

JF - Methods of Information in Medicine

SN - 0026-1270

IS - 4

ER -